M‐type phospholipase A2 receptor 1 (PLA2R1 or PLA2R1) was discovered 2009 as a new podocyte foot process protein targeted by autoimmunity in membranous nephropathy [181], which in the kidney is only expressed by podocytes. This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.